LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.87 | 27.76 | 759 | 604 | 1.2551 | 1.1049 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.68 | 27.76 | 1283 | 1119 | 1.1466 | 1.0520 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.06 | 27.76 | 8 | 360 | 0.0222 | -0.2858 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.17 | 27.76 | 998 | 489 | 2.0406 | 1.3761 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.28 | 27.76 | 1083 | 838 | 1.2913 | 1.1067 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.98 | 27.76 | 1275 | 941 | 1.3547 | 1.1231 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 5.36 | 27.76 | 706 | 320 | 2.2038 | 1.5020 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.76 | 27.76 | 864 | 401 | 2.1538 | 1.4407 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.17 | 27.76 | 219 | 489 | 0.4478 | 0.6471 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 15.58 | 27.76 | 963 | 685 | 1.4047 | 1.1524 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 15.58 | 27.76 | 1112 | 685 | 1.6220 | 1.2204 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.28 | 27.76 | 1193 | 838 | 1.4224 | 1.1486 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.98 | 27.76 | 1182 | 941 | 1.2559 | 1.0917 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 1.95 | 27.76 | 620 | 225 | 2.7538 | 1.7971 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.66 | 27.76 | 663 | 283 | 2.3351 | 1.5753 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 5.36 | 27.76 | 3 | 320 | 0.0094 | -0.4677 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.06 | 27.76 | 815 | 360 | 2.2639 | 1.4947 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.76 | 27.76 | 36 | 401 | 0.0897 | 0.0698 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.46 | 27.76 | 96 | 438 | 0.2189 | 0.3656 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.46 | 27.76 | 933 | 438 | 2.1270 | 1.4174 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.87 | 27.76 | 1056 | 604 | 1.7463 | 1.2672 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.39 | 27.76 | 1315 | 1305 | 1.0071 | 1.0026 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.68 | 27.76 | 1358 | 1119 | 1.2136 | 1.0739 | MN20160318_Q01 | C03 |